Range Low Price High Price Comment
30 days $83.44 $92.16 Wednesday, 27th Mar 2024 BMRN stock ended at $88.61. This is 0.99% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 0.90% from a day low at $87.94 to a day high of $88.74.
90 days $83.44 $99.25
52 weeks $76.02 $100.38

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2021-05-10 $77.29 $77.70 $75.81 $76.39 710 482
2021-05-07 $79.00 $79.83 $77.07 $77.77 625 110
2021-05-06 $78.00 $79.00 $77.34 $78.61 774 743
2021-05-05 $78.14 $79.10 $77.20 $77.68 867 227
2021-05-04 $78.71 $78.79 $77.25 $78.35 896 823
2021-05-03 $78.30 $79.28 $77.62 $78.68 812 874
2021-04-30 $79.69 $79.85 $77.24 $77.92 1 445 936
2021-04-29 $81.29 $81.75 $79.68 $80.18 726 844
2021-04-28 $80.00 $80.66 $79.49 $80.46 529 403
2021-04-27 $81.00 $81.28 $79.64 $79.77 867 461
2021-04-26 $79.20 $81.41 $78.61 $81.16 786 134
2021-04-23 $79.34 $80.19 $78.60 $78.73 719 660
2021-04-22 $78.91 $80.18 $78.29 $79.70 701 877
2021-04-21 $79.80 $79.80 $78.07 $79.33 921 118
2021-04-20 $79.51 $80.59 $79.03 $79.45 722 950
2021-04-19 $79.58 $79.95 $79.01 $79.59 974 383
2021-04-16 $79.12 $79.60 $78.07 $79.40 867 973
2021-04-15 $76.72 $79.64 $76.72 $78.77 1 253 180
2021-04-14 $78.25 $79.35 $77.98 $78.23 664 757
2021-04-13 $77.44 $78.29 $76.50 $77.77 863 490
2021-04-12 $76.56 $77.45 $76.38 $77.11 786 870
2021-04-09 $78.02 $78.79 $76.47 $77.07 760 442
2021-04-08 $78.45 $78.92 $77.95 $78.23 903 631
2021-04-07 $78.40 $79.85 $77.75 $78.05 958 389
2021-04-06 $78.63 $79.13 $78.30 $78.40 974 630
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT